Treatment of Pneumoniae: A Comparison of the Effects of Colistin and Ceftazidime-Avibactam

Abstract

This study compares the cure rate, risk, and benefit-risk of two drugs used to treat pneumonia by surveying statistics from five U.S. hospitals. Data from the past few years show that bacterial pneumonia is a highly contagious and pathogenic disease that is spreading worldwide. A review of the data compiled from previous studies concluded that there are two main drugs used for the treatment of pneumonia and that the two drugs use different mechanisms in the treatment of pneumonia. One is a combination of antibiotics to which bacterial resistance has been found to develop, while the other has been shown to be potentially harmful to the human renal system and nervous system. Therefore, the selection of the appropriate drug in combination with the patient’s complex multispecies infection is an important future research direction.